The Effect of Gamisamryungbaekchul-san(加味蔘苓白朮散) on the Tumor and Immune Response in Mouse B16 Melanoma Tumor Model

가미삼령백출산(加味蔘苓白朮散)의 B16 흑색종 암모델에 대한 항종양효과(抗腫瘍效果)와 면역증강효과(免疫增强效果)에 관한 연구(硏究)

  • Iem Cheol-Hong (Dept. of Preventive Medicine, College of Oriental Medicine, Kyung-Hee University) ;
  • Keum Jong-Chul (Dept. of Preventive Medicine, College of Oriental Medicine, Kyung-Hee University) ;
  • Lee Sang-Jae (Dept. of Preventive Medicine, College of Oriental Medicine, Kyung-Hee University) ;
  • Kim Kwang-Ho (Dept. of Preventive Medicine, College of Oriental Medicine, Kyung-Hee University)
  • 임철홍 (경희대학교 한의과대학 예방의학교실) ;
  • 금종철 (경희대학교 한의과대학 예방의학교실) ;
  • 이상재 (경희대학교 한의과대학 예방의학교실) ;
  • 김광호 (경희대학교 한의과대학 예방의학교실)
  • Published : 2001.06.29

Abstract

Background : Gamisamryungbaekchul-san(加味蔘?白朮散) is a herbal medicine which has been used for the traditional therapeutic agent of augmentation of the spleen and reinforcement of the Qi. Objective : This Study was performed to investigate the effect of Gamisamryungbaekchul-san on the tumor and immune response in the moose B16 melanoma tumor model. Materials and Methods : The tumor was induced by subcutaneous inoculation of B16BL6 melanoma cells in the shaved dorsal region of mice. Mice were orally administered with Gamisamryungbaekchul-san extract(26.3mg/mouse) for 14days after inoculation. For making examination of antitumor effect, the Increase of life span, Tumor growth inhibition rate, change of body weight were measured and evaluated. For the immune response increasing effect, the percentage of T lymphocyte and B Lymphocyte in the peripheral blood, the percentage of CD4+ T-cell, CD8+ T-cell and CD4+/CD8+ ratio in the peripheral blood and spleen, interleukin-2 productivity were measured and evaluated. Results : Gamisamryungbaekchul-san showed 16.59% increase of life span, 31.64% tumor growth inhibition rate and increase of body weight. Gamisamryungbaekchul-san increased the percentage of T lymphocyte in the peripheral blood, CD4+ T cell percentage of peripheral blood and spleen, and Interleukin-2 productivity as compared with the Control group. Whereas Gamisamryungbaekchul-san had no effect on the percentage of B lymphocyte in the peripheral blood, the percentage of CD8+ T cell, CD4+/CD8+ T-cell ratio in both of peripheral blood and spleen as compared with the Control group. Conclusion : This study shows that Gamisamryungbaekchul-san has anti-tumor effects and immunoregulatory effects on the B16 melanoma tumor model. It is suggested that Gamisarmyungbaekchul-san could be a useful immunomodulator and anti-tumor agent.

Keywords

References

  1. 東醫豫防醫學 김광호
  2. 면역의 의미론 타다 토미오
  3. 細胞分子免疫學 김광혁;김영상(외 23人)
  4. 晴崗醫鑑 金永勳
  5. 東醫病理學 안규석;문준전;최승훈
  6. 병태생리학 김창종
  7. 精校黃帝內經素問 洪元植(編著)
  8. 精校黃帝內經靈樞 洪元植(編著)
  9. 면역학 서울대학교 의과대학(編)
  10. 종양학 서울대학교 의과대학(編)
  11. 方藥合編 黃度淵
  12. 太平蕙民和劑局方 진사문(등)
  13. 醫方集解 王昻
  14. 死因原因統計年報 1980-1987
  15. 경희대한의대대학원 박사학위논문 補中益氣湯, 人參 및 黃 藥鍼이 免疫機能低下에 미치는 影響 김정헌
  16. 경희한의대논문집 v.18 보중익기탕, 수점산 및 보중익기탕 합 수점삼의 항암과 면역조졸작용에 관한 실험적 연구 한성규;최승훈;안규석
  17. 대한한방종양학회지 v.2 십전대보탕, 와송 및 십전대보탕가와송의항암효과와 면역반응에 관한 연구 황규동;류봉하;박동원
  18. 동의학회지 v.2 no.1 3-MCA 유발 上皮腫에 대한 海藻玉壺湯과 昆布의 항종양효과와 면역반응에 미치는 영향 이종률;채병윤
  19. 경희의학 v.12 no.3;4 양화탕 및 양화탕가미방의 항암효과와 면역반응에 관한 실험적 연구 유혜정;채병윤
  20. 대한소화기병학회지 v.24 no.3 위암환자에 있어서 말초혈의 T세포 Subset와 Natural Killer 세포에 관한 연구 정주섭;허윤;김순호
  21. 대한내과학회잡지 v.33 no.3 각종 악성 종양질환에서의 세포성 면역기능에 대한 연구 조덕연;성인환;이헌영;김상용;신영태;노홍규;이복희
  22. 경희한의대논문집 v.15 선방활명음의 항암 및 면역반응에 관한 실험적 연구 최인화;채병윤
  23. 대한내과학회지 v.31 no.2 폐암환자의 말초혈액내 T임파구의 아형 및 면역반응 박해심(등)
  24. 대한면역학회지 v.16 no.4 종야마우스 비장세포와 IL-2 생산과 마이토젠으로 유도한 세포증식반응 박형주;김금재;하대유
  25. 대한한의학회지 v.11 면역질환의 한방개념과 치료에 관한 문헌적 고찰 채우석
  26. 中華腫瘤治療大成 潘敏求;藜月恒;陳저(編)
  27. 諸病源候論校注 巢元方
  28. 現代中醫藥應用與硏究大系, 腫瘤科 v.14 施杞(主編)
  29. 醫宗金鑑 吳謙
  30. 黃帝內經素問今釋 王埼;李炳文;邱德文;王庄其;彭榮琛(編)
  31. 外科證治全生集 王維德
  32. 腫瘤硏究 郁仁存;姜延良;于爾辛(編)
  33. 中醫腫瘤學 v.上冊 郁仁存
  34. 實用中醫方劑學 游士勳;長錦淸
  35. 抗癌中藥藥理與應用 李宇彬(主編)
  36. 抗腫瘤中藥的臨床應用 張民庚;공惠明(主編)
  37. 萬病回春 공廷賢
  38. 中藥學 顔正華
  39. 中醫免疫學 載新民
  40. 外科正宗 陳實功
  41. 中華名醫名方薪傳 崔應珉
  42. J. Immunol. v.135 no.3 The mechanism of tumor growth inhibition by tumor-specific Lyt-1+2- T cells Fujiwara, H.;Takai, Y.;Sakamoto, K.;Hamaoka, T.